Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations: investors.bio-techne.com
Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q4 2019 Results - Earnings Call Transcript Bio-Techne Corporation (NASDAQ: TECH Company Participants Chuck Kummeth - CEO Jim Hippel - CFO Conference Call Participants Puneet Souda - SVB Leerink Catherine Schulte - Baird Dan Leonard - Deutsche Bank Patrick Donnelly - Goldman Sachs Alex Nowak - Craig-Hallum Capital Group Paul Knight - Janney Operator Good morning and welcome to the Bio-Techne Earnings Conference Call for the Fourth Quarter of Fiscal Year 2019. At this time, all participants have been placed in a listen-only mode and the call will be opened for questions following management's prepared remarks. I would now like to turn the call over to Mr. Jim Hippel, Bio-Techne's Chief Financial Officer. Please go ahead, sir. Thank you. And good morning. And thank you for joining us. On the call with me this morning is Chuck Kummeth, Chief Executive Officer of Bio-Techne. Before we begin, let me briefly cover our Safe Harbor statement.
[Read more]
| Impact snapshot | Event time: | TECH | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
TECH alerts
TECH alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Bio-Techne Announces ISO 14001:2015 Certification for the EMEA region of Bio-Techne.PR Newswire
- Stifel upgrades Bio-Techne to buy from hold, boosts price target [Seeking Alpha]Seeking Alpha
- Bio-Techne signs a license agreement with Luminary Therapeutics [Seeking Alpha]Seeking Alpha
- Bio-Techne Co. (<a href="https://www.marketbeat.com/stocks/NASDAQ/TECH/price-target/">NASDAQ: TECH</a>) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $435.00 price target on the stockMarketBeat
- Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster™ for the development of Luminary's CAR-T cell therapiesPR Newswire
- More
TECH
SEC Filings
- 2/18/21 - Form 4
- 2/17/21 - Form 4
- 2/17/21 - Form 4
- TECH's page on the SEC website
- More